project id: TCGA-CESC; case submitter id: TCGA-VS-A8QM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 7.9; age at index: 47; days to birth: -17168; days to death: 951; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; year of birth: 1962; year of death: 2011; age at diagnosis: 17168; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic t: TX; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IVB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.8767123287671232; pack years smoked: 16.0; is ffpe: false; composition: Not Reported; days to collection: 1422; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VS-A8QM-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 15.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;